IMMUNINE
BAXTER
Identification
- Active ingredient (INN)
- FACTEUR IX DE COAGULATION HUMAINE
- Internal code
- 12 J 104
- Country of Origin
- Austria
- Pharmaceutical form
- Lyophilised Powder + Solvent for Inj. or Perf.
- Prescription List
- Highly Regulated (List I)
- Packaging
- b/1fl. de pdre. lyoph.+1fl. de 5ml de solv. (e.p.p.i)+1aiguille de transferet+1aiguiile d'aeration+1aiguille filtre+1aiguille jetable+1seringue jetable (5ml)+1dispositif de perfusion
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Indications
Used to prevent or control bleeding in individuals with a deficiency in the level of the ninth clotting agent, as well as in persons with hemophilia b.
Associated Conditions
Carefully used under the supervision of a doctor in the following cases: pregnancy and breastfeeding; liver diseases; coronary heart and artery diseases; other coagulation disorders, including blood coagulation in the blood vessels; and immune system disorders.
Mechanism of Action
One of the blood clotting agents, based on vitamin K, that is synthesized in the liver, is activated by factor XIa, in the internal clot path, which eventually turns prothrombin into thrombin, and shapes clot.
Do you have questions related to this subject? Ask Sina, artificial intelligence to answer all your medical questions, write your question here, Sina, prepare the answer to you.